Mesothelioma Imaging Tests: X-Rays, CT, PET-CT and MRI
Imaging tests help doctors investigate symptoms, locate abnormal pleural or peritoneal tissue and determine how far a suspected mesothelioma may have spread. A scan can raise or lower clinical suspicion, but it cannot confirm the diagnosis without laboratory evaluation of cells or tissue.
The type and sequence of imaging depend on the location of the abnormality, previous results, the patient’s health, and whether the medical team is investigating symptoms, planning a biopsy, staging confirmed disease, or assessing treatment response.
Key takeaway
Contrast-enhanced CT is usually the central imaging examination for suspected pleural mesothelioma. PET-CT, MRI, ultrasound and chest X-rays provide additional information in selected situations, but no scan can establish the final histologic diagnosis by itself.
How Imaging Is Used in Mesothelioma Care
Imaging rarely does just one job. The same patient might have a chest X-ray to investigate breathlessness, a CT scan to map the extent of disease, and a follow-up scan months later to see whether treatment is working. Each step answers a different question.
Symptoms or Exam Finding
Breathlessness, chest discomfort or abdominal swelling prompts a first look.
Initial Imaging
A chest X-ray or ultrasound often comes first and may prompt more detailed imaging.
Cross-Sectional Imaging
CT, and sometimes PET-CT or MRI, maps the extent of any abnormality.
Biopsy Planning
Imaging helps identify an accessible site for tissue sampling.
Staging, Treatment and Follow-Up
Further scans support staging, treatment planning and monitoring over time.
Along the way, imaging may help clinicians identify pleural or peritoneal fluid, detect pleural thickening or nodularity, spot a mass, select an accessible biopsy site, evaluate nearby structures, look for lymph node involvement, check for distant disease, establish a baseline before treatment, compare changes over time, and investigate new symptoms as they arise.
The sequence above is a guide, not a fixed protocol. Biopsy, staging and additional imaging may overlap, particularly when symptoms need prompt management or when earlier scans from another hospital are already available. Some patients skip steps; others need to repeat one more than once.
This page focuses on what imaging can show and how it is used. For how doctors confirm mesothelioma through tissue and fluid samples, see our guide to tests and biopsy. For the broader diagnostic pathway, visit our diagnosis overview.
Comparing Mesothelioma Imaging Tests
No single scan does everything. The table below summarizes what each test is generally used for and where its limits lie.
| Test | Main Role | Uses Radiation? | Contrast or Tracer | Common Limitation |
|---|---|---|---|---|
| Chest X-ray | Initial evaluation of chest symptoms or an incidental abnormality | Yes, a small amount | Usually none | Cannot reliably characterize or stage pleural disease |
| Contrast-enhanced CTCentral test | Detailed assessment of pleural or peritoneal abnormalities and disease extent | Yes | Usually intravenous iodinated contrast | Cannot provide tissue confirmation and can underestimate subtle invasion |
| Thoracic or abdominal ultrasound | Fluid detection and image guidance for selected procedures | No | None | Limited overview of deep thoracic disease; not a complete staging test |
| FDG PET-CT | Metabolic assessment and detection of selected nodal or distant disease | Yes | Radiolabeled tracer (FDG) | Inflammation and prior pleural procedures can cause false-positive uptake |
| MRI | Additional soft-tissue detail and selected local staging questions | No ionizing radiation | Sometimes gadolinium contrast | Longer exam, motion-sensitive, not routinely required for every patient |
Chest X-Ray
A chest X-ray is often the first imaging test ordered when someone reports shortness of breath, chest discomfort, a persistent cough, reduced breath sounds on examination, or suspected fluid around the lung.
Possible findings include a pleural effusion affecting one side of the chest, pleural thickening, reduced expansion on the affected side, volume loss, an abnormal opacity, or elevation and obscuring of the diaphragm. None of these findings are specific to mesothelioma — the same appearances can show up with infection, heart failure, or other lung and pleural conditions.
A normal chest X-ray does not reliably rule out early or limited pleural disease. When the film looks suspicious, or when symptoms persist despite a normal result, the next step is usually a more detailed scan, most often CT.
What to expect
A chest X-ray is quick and typically does not require an injection. You may be asked to stand and hold your breath briefly, or to change position so the technologist can capture more than one view. The exam uses a small amount of ionizing radiation; the exact dose depends on the equipment and protocol used at your facility.
CT Scans for Suspected Mesothelioma
CT scanning uses X-rays and computer reconstruction to build detailed cross-sectional images of the body. For suspected pleural mesothelioma, contrast-enhanced CT is generally the central imaging examination — the scan most doctors reach for once a chest X-ray or symptoms raise concern.
Not every patient receives the identical protocol. A scan may cover the chest alone, extend into the upper abdomen, or include the full abdomen and pelvis in selected situations. The exact protocol depends on tumor location, symptoms, previous imaging, local practice, kidney function, contrast suitability, and what the treatment team needs to plan next.
CT can assess pleural effusion, pleural thickening, pleural nodules, involvement of the fissures between lung lobes, circumferential pleural growth, compression of the lung, chest wall involvement, diaphragmatic involvement, mediastinal structures, lymph nodes, findings on the opposite side of the chest, and upper abdominal or abdominal abnormalities, including possible distant lesions. No single CT sign, on its own, is considered diagnostic.
Suspicious CT patterns
Radiologists tend to grow more concerned when a scan shows a combination of findings rather than just one: nodular pleural thickening, circumferential thickening around the lung, involvement of the mediastinal pleura, nodularity along the fissures, an associated pleural effusion, contraction or volume loss of the affected side of the chest, and extension toward the chest wall or diaphragm. These findings can increase suspicion for pleural malignancy, but they are not sufficient to determine the exact cancer type.
CT for biopsy planning
Beyond diagnosis, CT often does practical work: it can help identify a focal pleural target, a chest wall mass, an abdominal target, a safer needle path, or an area likely to yield more useful tissue. This is one of the main ways imaging connects to tests and biopsy — the scan doesn’t make the diagnosis, but it often decides where the biopsy needle goes.
Limitations of CT
CT has real limits. It may not reliably determine microscopic invasion, every area of chest wall involvement, every small lymph node metastasis, the histologic subtype, whether all of the visible pleural thickening is actually malignant, or whether viable tumor is present in every abnormal-looking area. Surgical and pathologic findings occasionally differ from what was seen on imaging beforehand — a scan is an estimate of disease extent, not a final map.
CT Contrast and Preparation
Before a contrast-enhanced CT, the radiology team typically asks about previous contrast reactions, kidney disease, recent kidney-function tests, pregnancy or possible pregnancy, current medications, diabetes, asthma or significant allergies, difficulty lying flat, and venous access.
Do not stop any prescribed medication unless the radiology or medical team specifically instructs you to do so.
Intravenous iodinated contrast helps distinguish blood vessels, pleural tissue, chest wall structures, abdominal organs, and selected lymph nodes or masses from the surrounding tissue. Preparation requirements — including whether and how long to fast — vary by imaging center, so it’s best to follow the specific instructions your radiology department gives you rather than a generic rule.
Most contrast-enhanced CT examinations are completed without a serious complication. A brief sensation of warmth during injection is common and expected. Allergic-type reactions and kidney-related concerns are uncommon but require individual assessment — contrast is not risk-free, which is exactly why the questions above matter.
Thoracic and Abdominal Ultrasound
Ultrasound uses sound waves rather than ionizing radiation, which makes it useful for quick, repeatable looks at fluid and for guiding procedures in real time.
Thoracic ultrasound
Thoracic ultrasound is particularly good at confirming pleural fluid, estimating how much is accessible, and identifying septations or loculations within it. It’s commonly used to guide thoracentesis, chest-drain placement, and selected pleural biopsies, helping the clinician choose a safer procedural site. What it cannot do is provide the same complete overview of the pleura, chest wall, mediastinum, and distant organs that CT can.
Abdominal ultrasound
In the abdomen, ultrasound may help identify ascites, accessible peritoneal abnormalities, liver changes, and a target for paracentesis or selected biopsy procedures. CT or MRI is often still needed for a more complete evaluation.
What to expect
Ultrasound usually does not require an injection. A technologist or radiologist applies gel and moves a handheld probe over the area being examined, and you may be asked to change position. Preparation instructions vary depending on which part of the body is being scanned.
PET-CT for Mesothelioma Staging
FDG PET-CT combines two kinds of information in one exam: metabolic activity from PET, and anatomical detail from CT. Patients receive an injection of FDG, a radiolabeled tracer that behaves somewhat like glucose and is taken up by many metabolically active tissues — not exclusively by tumors.
PET-CT may help identify metabolically active pleural or peritoneal sites, evaluate suspicious lymph nodes, detect unexpected distant disease, clarify certain indeterminate findings from earlier scans, and in some cases help select a biopsy target. It contributes to staging and can inform treatment planning, particularly when finding distant disease would change the management plan.
One detail that surprises many patients: the CT portion built into a PET-CT is not always equivalent to a dedicated diagnostic-quality contrast-enhanced CT. The medical team may still request a separate CT for that reason.
PET activity does not automatically mean cancer. Inflammation, infection, healing tissue and previous procedures may also take up FDG. PET-CT findings must be interpreted alongside CT images, medical history, prior procedures and pathology results.
This matters especially for one common scenario: previous talc pleurodesis can cause persistent inflammatory FDG uptake and pleural thickening, sometimes long after the procedure. The radiologist needs to know whether and when pleurodesis was performed, or the scan can be misread.
PET-CT may also be less informative when lesions are very small, tumor activity is relatively low, blood glucose is not well controlled, inflammation is present, or treatment-related changes are present. A low-uptake area is not necessarily benign, and a high-uptake area is not necessarily malignant — both still need clinical correlation.
Getting ready for PET-CT
Instructions vary by imaging center but commonly include fasting for a specified period, drinking plain water, avoiding strenuous exercise beforehand, reviewing diabetes medications and checking blood glucose, and resting quietly after the tracer injection to allow it to distribute through the body. Follow the exact instructions your imaging center provides rather than a general rule of thumb.
When MRI May Be Helpful
MRI uses a strong magnetic field and radio waves rather than ionizing radiation. It may be requested to add detail about chest wall soft tissues, diaphragmatic involvement, spinal or neural extension, nearby blood vessels, selected mediastinal structures, surgical-planning questions, and, in selected cases, peritoneal disease.
MRI is complementary to CT, not a replacement for it, and it is not routinely necessary for every patient. It can be more difficult to complete when the patient cannot lie still, when breathing motion affects image quality, in cases of severe claustrophobia, when certain implanted devices are present, or simply because the exam runs long. Gadolinium contrast, when used, requires its own individual consideration.
Many modern implants are MRI-compatible or MRI-conditional, but the imaging team must verify the exact device before the examination — this isn’t a decision patients should make on their own.
What to report before an MRI
Pacemakers or other implanted heart devices, aneurysm clips, cochlear implants, neurostimulators, metal fragments, previous surgery involving implants, kidney disease, pregnancy or possible pregnancy, and claustrophobia. Mentioning these early gives the imaging team time to plan around them.
Imaging Peritoneal Mesothelioma
Imaging for mesothelioma isn’t only a chest story. When peritoneal mesothelioma is suspected or confirmed, CT of the abdomen and pelvis is the imaging test most commonly used.
Potential findings include ascites, peritoneal thickening, peritoneal nodules, omental thickening or an omental mass, mesenteric involvement, serosal abnormalities, abdominal masses, displacement of bowel loops, abnormalities on the surface of organs, enlarged lymph nodes, and occasionally findings outside the abdomen. As with pleural disease, none of these appearances are unique to mesothelioma — other cancers, infections, and inflammatory conditions can look similar on a scan.
MRI may add information in selected centers or when treatment planning calls for it, and PET-CT can sometimes contribute to staging or help target a biopsy, though its role here depends on the individual case and the experience of the center involved.
Rare mesothelioma locations
Mesothelioma involving the pericardium or the tunica vaginalis is rare, and imaging is tailored to whichever area is affected. Depending on the location, the medical team may use echocardiography, cardiac CT, cardiac MRI, scrotal ultrasound, or CT and MRI of the adjacent structures. For a fuller picture of these rare presentations, see our guide to types of mesothelioma.
What Imaging Can and Cannot Tell Doctors
Imaging can help show
- Where the abnormality is located
- Whether fluid is present
- The pattern of pleural or peritoneal involvement
- Whether nearby structures appear involved
- Whether lymph nodes look suspicious
- Whether distant abnormalities are visible
- Which area may be suitable for biopsy
- How findings change over time
Imaging cannot reliably determine by itself
- The exact histologic type
- Whether every area of thickening is malignant
- Whether microscopic invasion is present
- Whether a small node contains cancer
- Whether an FDG-avid area is definitely malignant
- Whether a non-avid area is definitely benign
- Which treatment will work
- An individual patient’s prognosis
Imaging can guide the next step, but pathology usually provides the confirmation.
Understanding the Radiology Report
Radiology reports are written for other physicians, so a few recurring terms are worth knowing before you read one.
Pleural effusion
Fluid between the layers surrounding the lung.
Pleural thickening
An area where the pleura looks thicker than expected. It can have malignant or nonmalignant causes.
Nodular pleural thickening
Irregular or nodular thickening that may increase concern for malignancy, without identifying the exact tumor type.
Fissural involvement
Thickening or nodularity along the fissures between the lung’s lobes.
Atelectasis
Partial collapse or reduced expansion of part of the lung.
Volume loss
A reduction in the volume of the affected lung or side of the chest.
Chest wall invasion
Imaging concern that abnormal tissue extends into the chest wall’s tissues or ribs. Imaging suspicion isn’t always identical to surgical or microscopic confirmation.
Lymphadenopathy
Lymph nodes that appear enlarged or abnormal. Size alone can’t always establish whether a node contains cancer.
Indeterminate
A finding that can’t be confidently classified from the available scan.
Correlate clinically
The radiologist is recommending the scan be read alongside symptoms, examination, lab findings, previous imaging, or pathology.
Recommend tissue sampling
The radiologist believes biopsy or cytology may help establish the diagnosis.
A radiology report is meant to be reviewed with your treating clinician, not interpreted in isolation.
Imaging for Staging
Staging describes the anatomical extent of confirmed or strongly suspected disease, and imaging is a major part of how that picture gets built. Scans may assess pleural distribution, local invasion, chest wall involvement, diaphragmatic involvement, mediastinal involvement, disease on the opposite side of the chest, lymph nodes, peritoneal or abdominal disease, and distant metastases.
In practice, clinical staging usually combines more than one source of information: contrast-enhanced CT, PET-CT, MRI in selected cases, invasive lymph-node evaluation, laparoscopy or other procedures for selected treatment candidates, and eventually surgical and pathology findings. Imaging alone doesn’t provide perfect staging accuracy.
The stage assigned before treatment may occasionally change after surgery or additional pathology, because microscopic disease can’t always be seen on a scan.
For a full explanation of how stages are defined, see our guide to mesothelioma stages.
Imaging before treatment
Beyond staging on paper, pre-treatment imaging helps the team figure out whether disease appears localized or extensive, whether surgery is worth considering, which specialists need to be involved, whether radiation planning makes sense, which areas need attention before systemic treatment starts, whether a measurable baseline exists for comparison later, and whether additional biopsy or staging procedures are still needed.
Scan findings are only part of the picture. Treatment decisions also depend on pathology, the histologic pattern identified in tissue, symptoms, lung function, heart function, general health, patient preferences, and review by a multidisciplinary team. Learn more about treatment options or find a specialist to discuss what a specific scan might mean for your situation.
Monitoring Treatment Response
Follow-up CT is commonly used to compare disease over time, but pleural mesothelioma is genuinely difficult to measure. Rather than growing as a single round mass, it often spreads as an irregular rind wrapping around the lung, which doesn’t fit neatly into standard tumor-measurement rules.
To handle this, radiologists may use mesothelioma-specific modified RECIST measurements, which assess pleural tumor thickness at standardized locations on the scan. This gives a more consistent way to compare images over time, particularly in clinical trials and specialist practice. It’s a tool for trained radiologists and oncologists to apply consistently — not something patients are expected to measure on their own scans.
Scan interpretation during treatment typically looks at pleural thickness, any new lesions, lymph nodes, distant disease, pleural fluid, and how all of that lines up with symptoms, treatment timing, and previous procedures.
Immunotherapy adds another wrinkle: treatment-related inflammation can sometimes complicate how a scan looks. A single scan may not tell the whole story, and the oncology team may lean on symptoms, examination, lab results, and repeat imaging together rather than one image in isolation. A stable scan is reassuring, but it doesn’t automatically guarantee that treatment is working, and small measurement differences between two scans don’t always mean the disease is progressing.
Imaging after pleurodesis or surgery
Prior treatment can change how a scan looks. Pleural thickening after pleurodesis, dense pleural material from talc, persistent FDG uptake from inflammation, postoperative fluid, scarring, and other healing-related changes can all appear on later scans and complicate the picture.
Always tell the imaging team about previous pleural procedures, including thoracoscopy, biopsy, chest drains, pleurodesis and surgery. The date and type of procedure can materially affect how the scan is interpreted.
Can Imaging Screen for Mesothelioma?
There is no universally established population-screening program specifically proven to detect mesothelioma early and reduce mortality. That said, some people with known asbestos exposure undergo occupational or specialist medical follow-up, and imaging decisions in that setting depend on symptoms, smoking history, age, exposure history, and any applicable local programs.
Low-dose CT screening may be recommended for lung cancer in people who meet separate lung-cancer screening criteria — but lung-cancer screening and mesothelioma screening are not the same thing, and meeting one set of criteria doesn’t automatically mean the other applies. A normal scan today cannot guarantee that mesothelioma won’t develop later, and neither blood biomarkers nor routine chest X-rays are established stand-alone screening solutions for mesothelioma.
People with known asbestos exposure should discuss an individualized follow-up plan with a qualified clinician rather than scheduling repeated scans without medical guidance.
Getting a Second Imaging Opinion
A second radiology review can be valuable when findings are unclear, when mesothelioma is strongly suspected, when the report and pathology don’t seem to match, when surgery or complex multimodality treatment is being considered, when previous procedures complicate interpretation, when several scans from different hospitals need comparing, or when a patient is being referred to a specialist center.
For that review, patients may be asked to provide the written radiology report, the original scan images, prior scans for comparison, procedure dates, pathology reports, and treatment records. Original images are commonly transferred electronically or supplied in DICOM format — the technical details are handled by the imaging and referral teams, not something a patient needs to master.
A second opinion is collaboration, not a criticism of the original radiologist. Mesothelioma is uncommon enough that an additional set of experienced eyes often adds genuine value.
Preparing for an Imaging Appointment
Protocols vary between imaging centers, so there’s no single universal checklist — but a few things are worth having ready before most appointments.
- Bring an up-to-date medication list
- Report previous contrast reactions
- Report kidney problems
- Report diabetes and follow test-specific medication instructions
- Report pregnancy or possible pregnancy
- Report implanted devices before MRI
- Mention claustrophobia before MRI
- Follow fasting instructions exactly when required
- Avoid strenuous activity before PET-CT when instructed
- Bring previous scan reports and images when requested
- Tell the team about previous pleurodesis, chest procedures or surgery
- Ask whether transportation is needed if sedation is planned
Do not stop any prescribed medication unless the imaging or medical team specifically instructs you to do so.
Questions to Ask the Medical Team
- What is this scan expected to clarify?
- Why are you recommending this imaging test?
- Will I need contrast?
- Does the scan require fasting?
- Should I change any medication?
- Does my kidney function need to be checked?
- How should I manage diabetes before a PET-CT?
- Is this a diagnostic-quality CT or the CT portion of a PET-CT?
- Will the scan include my abdomen or pelvis?
- Could previous pleurodesis affect the result?
- Will the images help guide a biopsy?
- Do I need an MRI for local staging?
- When should I expect the report?
- Who will explain the result?
- Will my previous scans be compared?
- Could a specialist radiologist review the images?
- Will another test still be required?
- How will the scan influence treatment planning?
Frequently Asked Questions
Can imaging tests confirm mesothelioma?
No. Imaging can identify abnormalities that raise suspicion for mesothelioma, show where disease may be located, and help guide biopsy. Confirmation usually depends on laboratory examination of fluid or tissue by an experienced pathologist.
Which scan is most commonly used for pleural mesothelioma?
Contrast-enhanced CT is generally the main imaging examination used to evaluate suspected pleural mesothelioma. Other tests, including PET-CT or MRI, may be added when they can answer specific staging or treatment-planning questions.
What can a CT scan show in mesothelioma?
A CT scan may show pleural fluid, pleural thickening, nodules, fissural involvement, lung compression, and possible extension toward the chest wall, diaphragm or nearby structures. These findings are not specific enough to confirm mesothelioma without pathology.
Can a CT scan miss mesothelioma?
CT can miss very small, subtle or microscopic disease. It may also underestimate invasion of nearby structures or fail to determine whether a small lymph node contains cancer. A scan must be interpreted alongside symptoms, pathology and other clinical information.
Is PET-CT better than CT for mesothelioma?
The tests provide different information. Diagnostic CT gives detailed anatomical images, while PET-CT shows patterns of metabolic activity and may help identify selected nodal or distant disease. PET-CT does not replace diagnostic-quality CT or biopsy.
Can inflammation look like mesothelioma on PET-CT?
Yes. Infection, inflammation, healing tissue and previous procedures can show increased FDG uptake. Talc pleurodesis can cause persistent pleural uptake and must be considered when the scan is interpreted.
Is MRI required for every mesothelioma patient?
No. MRI is usually a complementary test used when additional soft-tissue detail may affect local staging, surgical planning, or evaluation of the chest wall, diaphragm, spine or other nearby structures.
What is ultrasound used for in mesothelioma?
Ultrasound is useful for detecting pleural or abdominal fluid and guiding procedures such as thoracentesis, paracentesis, chest-drain placement and selected biopsies. It is not a complete staging examination.
How should I prepare for a PET-CT scan?
Preparation varies by imaging center but may include fasting, avoiding strenuous exercise, drinking water, and following special instructions for diabetes medications. Patients should follow the exact instructions provided by the imaging facility.
Can imaging determine the stage of mesothelioma?
Imaging is a major part of clinical staging, but it is not perfectly accurate. The final understanding of disease extent may also use biopsy results, lymph-node sampling, surgery or other staging procedures.
What is modified RECIST for mesothelioma?
Modified RECIST is a standardized method specialists may use to measure pleural tumor thickness on CT and compare changes over time. It is designed for the unusual growth pattern of pleural mesothelioma and should be applied by trained professionals.
Should people exposed to asbestos have regular CT scans?
There is no universal CT-screening schedule specifically proven for mesothelioma. Follow-up should be individualized according to symptoms, age, exposure history, smoking history, and applicable lung-cancer screening recommendations.
Imaging Helps Define the Next Step
A scan can identify suspicious areas, guide tissue sampling and help determine the extent of disease. The final diagnosis and treatment plan usually require pathology review and discussion with a multidisciplinary mesothelioma team.
Medical disclaimer: This page provides general educational information and is not a substitute for medical evaluation, diagnosis or treatment. The choice and timing of imaging tests should be determined by the patient’s medical team based on symptoms, previous results, health status and the clinical question being investigated.
Sources and Medical Review
Written by the MesotheliomaFeed Editorial Team, using publicly available medical and radiology literature. Medical review status: Medical review pending. Last updated: July 28, 2026.
- National Cancer Institute — Mesothelioma Treatment (PDQ)
- International Mesothelioma Interest Group — consensus recommendations for imaging in mesothelioma
- American Society of Clinical Oncology — malignant pleural mesothelioma guideline update
- British Thoracic Society — guidance on the investigation and management of malignant pleural mesothelioma
- European respiratory and thoracic-surgery guidance on mesothelioma imaging and staging
- Modified RECIST 1.1 recommendations for pleural mesothelioma
- Peer-reviewed thoracic radiology literature on pleural and peritoneal mesothelioma imaging